Healthcare

Celltrion

068270

Samsung Biologics

207940

Biosimilars vs CMO - comparing two pillars of Korean bio industry

Celltrion

068270

KRX

₩190,000

▲ 3,000 (+1.60%)

Korea's largest biosimilar company. Global sales of blockbuster biosimilars including Remsima and Truxima.

Samsung Biologics

207940

KRX

₩850,000

▲ 12,000 (+1.43%)

World's largest biopharmaceutical CMO/CDMO. Secured global No.1 production capacity with Plant 4 operational.

Key Metrics Comparison

Celltrion

Key Metrics Comparison

Samsung Biologics

₩190,000

Price

₩850,000

+1.60%

Change

+1.43%

22.7

P/E Ratio

55.8

₩40.8조

Market Cap

₩60.2조

₩230,000

52W High

₩1,020,000

₩165,000

52W Low

₩720,000

1.3M

Volume

95K

About the Companies

Celltrion

Korea's largest biosimilar company. Global sales of blockbuster biosimilars including Remsima and Truxima.

Samsung Biologics

World's largest biopharmaceutical CMO/CDMO. Secured global No.1 production capacity with Plant 4 operational.

※ All data is for reference only and not real-time. Investment decisions are the sole responsibility of the investor. This comparison is not investment advice.

Other Comparisons

Eli Lilly & Co. vs UnitedHealth Group

Healthcare

Celltrion vs Eli Lilly & Co.

Healthcare

Samsung Biologics vs UnitedHealth Group

Healthcare

Samsung Electronics vs Celltrion

blue-chip

SK Hynix vs Celltrion

Hyundai Motor vs Celltrion

blue-chip

LG Energy Solution vs Celltrion

blue-chip